Cordis, Wyeth Urge Fed. Circ. To Revive Stent Patents
A Federal Circuit panel on Friday mulled whether to reinstate two Cordis Corp. and Wyeth Pharmaceuticals Inc. drug-eluting stent patents nixed in an infringement battle with Abbott Laboratories and others, with...To view the full article, register now.
Already a subscriber? Click here to view full article